Clinical Trials Directory

Trials / Sponsors / Chengdu Kanghong Biotech Co., Ltd.

Chengdu Kanghong Biotech Co., Ltd.

Industry · 21 registered clinical trials2 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingFirst-In-Human Study of KHN922 for Injection
Advanced Solid Tumors Cancer
Phase 1 / Phase 22026-04-01
Not Yet RecruitingFirst-In-Human Study in Participants With Advanced Solid Tumors
Advanced Solid Tumors
Phase 12025-04-30
UnknownReal World Study of the Effectiveness and Safety of Conbercept Ophthalmic Injection in the Treatment of Retino
Retinopathy of Prematurity
2022-09-01
UnknownA Clinical Study on the Efficacy and Safety of VEC Intravenous Chemotherapy Combined With Conbercept Intravitr
Retinoblastoma
Phase 22021-07-05
UnknownPhase 2 Study of KH903 in Patients With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma As Second
Gastric Cancer, Gastroesophageal Cancer
Phase 22020-09-15
UnknownAn Exploratory Clinical Trial Evaluating the Tolerability and Efficacy of KH906 in Patients With Corneal Neova
Corneal Neovascularization
Phase 12019-07-18
TerminatedEfficacy and Safety Trial of Conbercept Intravitreal Injection for Neovascular AMD (PANDA-2)
Neovascular Age-related Macular Degeneration
Phase 32018-12-21
TerminatedEfficacy and Safety Trial of Conbercept Intravitreal Injection for Neovascular AMD (PANDA-1)
Neovascular Age-related Macular Degeneration
Phase 32018-09-25
UnknownPhase IV Clinical Trial (STAR Study) Extension Study of Conbercept Ophthalmic Injection for Treatment of Polyp
Polypoid Choroidal Vasculopathy (PCV)
Phase 42017-04-25
UnknownSafety Evaluation of China Patients: Long-term Treatment Outcome of Conbercept Ophthalmic Injection in Real Wo
Wet Age-related Macular Degeneration (wAMD)
2016-10-01
CompletedConbercept Ophthalmic Injection for Patients of Central Retinal Vein Occlusion
Macular Edema, Central Retinal Vein Occlusion
Phase 32016-05-24
CompletedConbercept Ophthalmic Injection for Patients With Macular Edema Caused by Branch Retinal Vein Occlusion
Branch Retinal Vein Occlusion, Macular Edema
Phase 32016-04-13
UnknownThe Efficacy Assessment of Intravitreal Injection of Conbercept in Patients With Polypoidal Choroidal Vasculop
Polypoidal Choroidal Vasculopathy (PCV)
Phase 42015-10-01
UnknownSafety and Efficacy Study of Conbercept in Diabetic Macular Edema (DME) (Sailing)
Diabetic Macular Edema
Phase 32014-07-01
UnknownA Randomized, Double-blind, Multicenter, Sham-controlled, Safety and Efficacy Study of Conbercept in Patients
Choroid Neovascularization Secondary to Degenerative Myopia
Phase 32012-08-01
UnknownEfficacy and Safety of Conbercept in Macular Edema Secondary to Retinal Vein Occlusion
Retinal Vein Occlusion
Phase 22012-05-01
UnknownAn Open, Single-center, Safety and Efficacy Study of Conbercept in Patients With Very Low Vision Secondary to
Very Low Vision Secondary to Wet Age-related Macular Degeneration
Phase 22011-12-01
CompletedA Randomized, Double-masked, Multicenter,Sham-controlled, Safety and Efficacy Study of KH902 in Patients With
Neovascular Age-related Macular Degeneration
Phase 32011-08-01
CompletedA Randomized, Double-masked, Multicenter, Controlled Study of Intravitreal KH902 in Patients With Neovascular
Neovascular Age-related Macular Degeneration
Phase 22010-05-01
CompletedSafety and Efficacy by Multiple Injection of KH902 in Patients With Diabetic Macular Edema (DME)
Diabetic Macular Edema
Phase 1 / Phase 22010-04-01
CompletedA Study Assessing the Safety and Efficacy of Multiple Intravitreal KH902 in Patients With CNV Due to AMD
Neovascular Age-related Macular Degeneration
Phase 1 / Phase 22009-08-01